Valneva SE (VALN) FCF Margin (2021 - 2026)
Valneva SE (VALN) posted quarterly FCF Margin of 0.21% for Q1 2026, up 1266.0% year-on-year from 0.02% in Q1 2025, and up 99.76% on a QoQ basis from 89.17% in Q4 2025.
Valneva SE (VALN) FCF Margin (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported FCF Margin for 6 consecutive years, with 0.21% the latest figure, recorded in Q1 2026.
- Quarterly FCF Margin rose 1266.0% year-over-year to 0.21% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36.57% (down 119.0% YoY) and the FY2025 annual result came in at 36.3%, up 1336.0% from the prior year.
- FCF Margin rose to 0.21% in Q1 2026 per VALN's latest filing, from 89.17% in the prior quarter.
- Over the last five years, FCF Margin for VALN reached as high as 151026.86% in Q3 2023 and fell as low as 143171.25% in Q2 2023.
- A 5-year average of 404.29% and a median of 69.97% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin jumped 15107951 bps — and 2024, when it sank 15103676 bps.
- Year by year, FCF Margin stood at 97.51% in 2022, then tumbled by 119 bps to 213.39% in 2023, then soared by 85 bps to 31.31% in 2024, then tumbled by 185 bps to 89.17% in 2025, then soared by 100 bps to 0.21% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 0.21%, 89.17%, and 69.97% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | -0.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.21% |
| Dec 31, 2025 | -89.17% |
| Sep 30, 2025 | -69.97% |
| Jun 30, 2025 | -2.83% |
| Mar 31, 2025 | -12.87% |
| Dec 31, 2024 | -31.31% |
| Sep 30, 2024 | -9.91% |
| Jun 30, 2024 | -97.86% |
| Mar 31, 2024 | -72.68% |
| Dec 31, 2023 | -213.39% |
| Sep 30, 2023 | 151,026.86% |
| Jun 30, 2023 | -143,171.25% |
| Mar 31, 2023 | -59.83% |
| Dec 31, 2022 | -97.51% |
| Sep 30, 2022 | -52.66% |
| Jun 30, 2022 | -92.46% |
| Mar 31, 2022 | -79.95% |
| Dec 31, 2021 | -43.40% |
| Sep 30, 2021 | -79.14% |
| Jun 30, 2021 | 245.17% |